Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Engerix-B 2-dose versus 3-dose hepatitis B vaccination in healthy adolescents
2015-001531-20Phase 3
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Hepatitis B vaccine and hepatitis B vaccine recombinant in hepatitis B (HBV) (2 arms), sponsored by GSK. Primary endpoint: Anti-hepatitis B surface antigen titers at Month 6.
02
Drugs
Hepatitis B vaccinehepatitis B vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2015-001531-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001531-20.